During the past decade, Piedmont Heart Institute- Fayetteville conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Piedmont Heart Institute- Fayetteville" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator, "IQVIA Biotech" with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Piedmont Heart Institute- Fayetteville" are "Heart Failure" (1 trials), "Iron-deficiency" (1 trials) and "Paroxysmal Supraventricular Tachycardia" (1 trials). Many other conditions were trialed in "Piedmont Heart Institute- Fayetteville" in a lesser frequency.

Most popular intervention types in "Piedmont Heart Institute- Fayetteville" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Etripamil" (1 trials) and "Ferric Carboxymaltose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Piedmont Heart Institute- Fayetteville" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Piedmont Heart Institute- Fayetteville". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Piedmont Heart Institute- Fayetteville, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Piedmont Heart Institute- Fayetteville, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".